Azole-resistant aspergillosis

Adilia Warris*

*Corresponding author for this work

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Azole-resistance in Aspergillus fumigatus is emerging and is becoming an increasing problem in the management of aspergillosis. Two types of development of resistance have been described; resistance acquired during azole treatment in an individual patient and through environmental exposure to fungicides. The main molecular mechanism of azole resistance in A. fumigatus is explained by mutations in the cyp51A-gene. The environmental route of resistance development is particularly worrying and may affect all patients whether azole exposed or naive, and whether suffering from acute or chronic aspergillosis. No management guidelines to assist clinicians confronted with azole-resistant aspergillosis are available and pre-clinical and clinical evidence supporting treatment choices is scarce. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)S121-S125
Number of pages5
JournalJournal of Infection
Volume71
Issue numberSupplement 1
Early online date25 Apr 2015
DOIs
Publication statusPublished - Jun 2015

Keywords

  • A. fumigatus
  • aspergillosis
  • azoles
  • resistance
  • allergic bronchopulmonary aspergillosis
  • nervous-system aspergillosis
  • liposonal amphotericin-B
  • invasive aspergillosis
  • antifungal agents
  • 1st-line therapy
  • CYP51A gene
  • fumigatus
  • voriconazole
  • posaconazole

Cite this

Azole-resistant aspergillosis. / Warris, Adilia.

In: Journal of Infection, Vol. 71, No. Supplement 1, 06.2015, p. S121-S125.

Research output: Contribution to journalArticle

Warris, A 2015, 'Azole-resistant aspergillosis', Journal of Infection, vol. 71, no. Supplement 1, pp. S121-S125. https://doi.org/10.1016/j.jinf.2015.04.023
Warris, Adilia. / Azole-resistant aspergillosis. In: Journal of Infection. 2015 ; Vol. 71, No. Supplement 1. pp. S121-S125.
@article{c3fa367248a64a2e8052b6e780afe457,
title = "Azole-resistant aspergillosis",
abstract = "Azole-resistance in Aspergillus fumigatus is emerging and is becoming an increasing problem in the management of aspergillosis. Two types of development of resistance have been described; resistance acquired during azole treatment in an individual patient and through environmental exposure to fungicides. The main molecular mechanism of azole resistance in A. fumigatus is explained by mutations in the cyp51A-gene. The environmental route of resistance development is particularly worrying and may affect all patients whether azole exposed or naive, and whether suffering from acute or chronic aspergillosis. No management guidelines to assist clinicians confronted with azole-resistant aspergillosis are available and pre-clinical and clinical evidence supporting treatment choices is scarce. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.",
keywords = "A. fumigatus, aspergillosis, azoles, resistance, allergic bronchopulmonary aspergillosis, nervous-system aspergillosis, liposonal amphotericin-B, invasive aspergillosis, antifungal agents, 1st-line therapy, CYP51A gene, fumigatus, voriconazole, posaconazole",
author = "Adilia Warris",
note = "Conflict of interest None to declare.",
year = "2015",
month = "6",
doi = "10.1016/j.jinf.2015.04.023",
language = "English",
volume = "71",
pages = "S121--S125",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "W B SAUNDERS CO LTD",
number = "Supplement 1",

}

TY - JOUR

T1 - Azole-resistant aspergillosis

AU - Warris, Adilia

N1 - Conflict of interest None to declare.

PY - 2015/6

Y1 - 2015/6

N2 - Azole-resistance in Aspergillus fumigatus is emerging and is becoming an increasing problem in the management of aspergillosis. Two types of development of resistance have been described; resistance acquired during azole treatment in an individual patient and through environmental exposure to fungicides. The main molecular mechanism of azole resistance in A. fumigatus is explained by mutations in the cyp51A-gene. The environmental route of resistance development is particularly worrying and may affect all patients whether azole exposed or naive, and whether suffering from acute or chronic aspergillosis. No management guidelines to assist clinicians confronted with azole-resistant aspergillosis are available and pre-clinical and clinical evidence supporting treatment choices is scarce. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

AB - Azole-resistance in Aspergillus fumigatus is emerging and is becoming an increasing problem in the management of aspergillosis. Two types of development of resistance have been described; resistance acquired during azole treatment in an individual patient and through environmental exposure to fungicides. The main molecular mechanism of azole resistance in A. fumigatus is explained by mutations in the cyp51A-gene. The environmental route of resistance development is particularly worrying and may affect all patients whether azole exposed or naive, and whether suffering from acute or chronic aspergillosis. No management guidelines to assist clinicians confronted with azole-resistant aspergillosis are available and pre-clinical and clinical evidence supporting treatment choices is scarce. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

KW - A. fumigatus

KW - aspergillosis

KW - azoles

KW - resistance

KW - allergic bronchopulmonary aspergillosis

KW - nervous-system aspergillosis

KW - liposonal amphotericin-B

KW - invasive aspergillosis

KW - antifungal agents

KW - 1st-line therapy

KW - CYP51A gene

KW - fumigatus

KW - voriconazole

KW - posaconazole

U2 - 10.1016/j.jinf.2015.04.023

DO - 10.1016/j.jinf.2015.04.023

M3 - Article

VL - 71

SP - S121-S125

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - Supplement 1

ER -